Condition: Lung Transplant · Pulmonary Hypertension · Sponsor: Mayo Clinic
The purpose of this study is to determine if transseptal extra-corporeal membrane oxygenation (ECMO) can bridge pulmonary hypertension- right heart failure (PH-RVF) patients to lung transplant safely.
This description comes directly from the study's public registry record.
Ian A Makey, MD · 9049531048 · makey.ian@mayo.edu
Mohammad E Alomari, MD · 9044283665 · alomari.mohammad@mayo.edu
Always discuss trial participation with your own doctor first.
| Mayo Clinic in Florida | Jacksonville, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06770023